T. Rowe Price Investment Management

Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.

Long-duration iron-air batteries designed to store electricity for multi-day grid needs.

Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD

SiFive licenses RISC-V processor intellectual property for custom computing chips, including high-performance data-centre designs.

Cellares manufactures cell therapies for drug developers using automated production and quality-control systems deployed through its Smart Factory network.

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

Kardigan develops cardiovascular medicines that target specific biological drivers of heart disease and the patient groups most likely to respond.